-
-
-
-
-
-
-
Press release: Sanofi successfully prices USD 3 billion of bond issue
-
-
-
-
-
-
-
Citi Reiterates Sell Rating on Blueprint Medicines (BPMC) As Co is Acquired
-
-
-
-
-
-
-
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
-
-
-
-
-
-
-
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
-
-
-
-
-
-
-
Inhibrx (INBX) Sells INBRX-101 to Sanofi (SNY) for Up to $2.2B
-
-
-
-
-
-
-
First Wave BioPharma (FWBI) Enters Exclusive Global License Agreement for Capeserod from Sanofi (SNY)
-
-
-
-
-
-
-
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

